Louise J. Barber - Concepedia

Author

Louise J. Barber

Cancer Research UK ORCID

Also Known As

Barber, Louise, L. Barber, L.J. Barber, LJ Barber, Louise Barber, Louise J Barber, Louise J. Barber, Shtessel, Ludmila

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Cancer Research UK Institute of Cancer Research Royal Marsden Hospital Royal Marsden NHS Foundation Trust University College London

About

Louise J. Barber is an author at Cancer Research UK specializing in medicine, genetics, and molecular genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.6K
2	Natural Sciences	3	3	387
3	Engineering	2	2	353
4	Health Sciences	1	1	21
5	Biomolecular Engineering	1	1	219

Louise J. Barber

Publications

Citations

H-Index

Page 1

	Year	Citations
RTEL1 Maintains Genomic Stability by Suppressing Homologous Recombination Louise J. Barber, Jillian L. Youds, Jordan D. Ward, Cell Genome InstabilityHomologous RecombinationGeneticsGenomic MechanismMolecular Genetics	2008	359
Secondary mutations in <i><scp>BRCA2</scp></i> associated with clinical resistance to a <scp>PARP</scp> inhibitor Louise J. Barber, Shahneen Sandhu, Lina Chen, The Journal of Pathology EngineeringGeneticsPathologyMolecular GeneticsTreatment Resistance	2012	334
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer Andrew Woolston, Khurum Khan, Georgia Spain, Cancer Cell Tumor BiologyCetuximab Resistance LandscapeImmune Landscape EvolutionColorectal CancersMedicine	2019	254
FANCJ Is a Structure-specific DNA Helicase Associated with the Maintenance of Genomic G/C Tracts Timothy London, Louise J. Barber, Georgina Mosedale, Journal of Biological Chemistry GeneticsGenomic MechanismMolecular BiologyMolecular GeneticsGenomic G/c Tracts	2008	243
A Critical Role for the Ubiquitin-Conjugating Enzyme Ubc13 in Initiating Homologous Recombination Guang Zhao, Eiichiro Sonoda, Louise J. Barber, Molecular Cell Protein BiosynthesisCritical RoleMolecular BiologyMolecular GeneticsUbiquitin-conjugating Enzyme Ubc13	2007	219
Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene <i>MSH2</i> Sarah A. Martin, Afshan McCarthy, Louise J. Barber, EMBO Molecular Medicine	2009	157
Efficacy of Chemotherapy in <i>BRCA1/2</i> Mutation Carrier Ovarian Cancer in the Setting of PARP Inhibitor Resistance: A Multi-Institutional Study Joo Ern Ang, Charlie Gourley, C. Bethan Powell, Clinical Cancer Research	2013	140
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment Alice Newey, B Griffiths, Justine Michaux, Journal for ImmunoTherapy of Cancer	2019	140
CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids Reyes Gonzalez-Exposito, Maria Semiannikova, B Griffiths, Journal for ImmunoTherapy of Cancer	2019	110
HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability Spencer J. Collis, Louise J. Barber, Allison J. Clark, Nature Cell Biology Genome InstabilityCell RegulationCell DivisionMolecular RegulationMolecular Biology	2007	109

Page 1